2024 New Treatment Grant Recipients
The New Treatment Grants fund projects at any stage (preclinical to clinical) that will significantly accelerate treatments to pancreatic cancer patients, and grow capacity in pancreatic cancer research in Australia. Grant applications were assessed by our Scientific Advisory Panel comprised of international and national experts in the field.
Accelerator Grants
Advancing a new targeted antibody to combat pancreatic cancer.
Enhancing the efficacy of and overcoming resistance to Kras Inhibitors in Pancreatic Cancer.
Targeting fibrosis to improve clinical KRAS G12D inhibitor MRTX1133 efficacy in pancreatic cancer.
Novel radiopharmaceutical therapies targeting tumour stroma for treating pancreatic cancer
